page-template,page-template-full_width,page-template-full_width-php,page,page-id-7636,elision-core-1.0.11,translatepress-it_IT,ajax_fade,page_not_loaded,qode-theme-ver-4.5,wpb-js-composer js-comp-ver-7.0,vc_responsive

Expected improvements in patients after our fetal stem cell therapy for ALS

Stable and positive clinical effects after our ALS treatment generally lasts for 4-6 months.

  • Decrease in weakness

  • Mood and appetite improvement

  • Decrease in fasciculations (twitching) and spasticity (muscle tightening)

  • Improvement in swallowing and speaking

  • Decrease in muscular rigidity, normalization of reflexes

  • Decrease in fasciculation zones

Amyotrophic Lateral Sclerosis (ALS) Fetal Stem Cell treatment at CellStemClinic

Amyotrophic lateral sclerosis (ALS) also known as motor neuron disease (MND) and Lou Gehrig’s disease, is a rare condition characterized by the degeneration of nerve cells that control voluntary muscles. The disease leads to gradually worsening symptoms that include muscle weakness, twitching, and stiffness. As more of these nerve cells, or motor neurons, are lost: muscles decrease in size and continue to weaken, eventually resulting in problems with speaking, swallowing, and breathing.

About treatment

CellStemClinic has much experience in treating ALS using fetal stem cells.

CellStemClinic’s ALS therapy opens new possibilities in treating this disease, potentially resulting in significant improvement of the patient’s motor activity with mental and emotional improvements.

Overall health and quality of life is generally much higher after fetal stem cell therapy. Numerous research works and personal experience of ALS patients treated at CellStemClinic clinic has proven this treatment to be absolutely safe for those living with ALS.

Currently, this therapy is considered the most modern and effective treatment method for ALS.

We offer 2 treatment programs for ALS patients.

  • 2-day treatment with intravenous and subcutaneous use of fetal stem cells: developed for patients with mild and moderate-to-severe ALS disease.

  • 3-day treatment with both intravenous, subcutaneous and intrathecal injections: specially developed for the patients with moderate-to-severe ALS disease. This program is designed to increase the effectiveness of therapy among our patients who have more advanced conditions and greater impairment of central nervous system damage.

Each treatment course includes a session with our physiotherapy specialist (physical therapist) to additionally support the physical abilities of the patient.

CellStemClinic Therapy

ALS/MND treatment


After treatment, CellStemClinic has observed most patients becoming stronger (increase in muscle strength), an increase of range of volume of motions in their extremities, improvement in gait, reduced fasciculations, reduction in coughing spells while eating, and normalization of swallowing, thus allowing the patient for better self-care.

It is important to understand that in order for a patient with ALS to maintain positive results for ALS after fetal stem cell treatment, it is recommended to repeat the therapy. CellStemClinic’s fetal stem cell therapy can slow down the disease development of ALS, and prolong the patient’s life.